Helicobacter pylori reinfection is virtually absent after successful eradication van 
The pathogenic role of Helicobacter pylori in chronic active pretreatment and recurrent strains were compared by restriction fragment length polymorphism (RFLP) or random-amplified gastritis and the association with duodenal ulcer disease in 95% -99% of patients are well established [1 -3] . Eradication polymorphic DNA (RAPD) techniques to distinguish between reinfection (different strain) and recrudescence (identical of H. pylori infection cures peptic ulcer disease and, conversely, relapses of peptic ulcer disease are associated with reappearstrain). ance of H. pylori infection [4] .
Data on reappearance of H. pylori infection following sucMaterials and Methods cessful eradication are conflicting and vary from 0 to 47% [5 -8] . Comparison of the results from reinfection studies is Patient selection. Dyspeptic H. pylori-positive patients rehampered by the difference in assessment of cure of the infecferred for diagnostic upper gastrointestinal endoscopy were intion, such as assessment within 4 weeks after completion of cluded in this follow-up study. All patients were enrolled between therapy (leading to an overestimation of cure and reinfection 1984 and 1994 and participated in various H. pylori eradication rates) [6, 8] , sampling error following eradication therapy trials. Patients who had previous gastric surgery; who were alcohol [4, 6 -10] , the use of less sensitive tests [10, 11] , and absence abusers; who had cardiac, pulmonary, hepatic, or renal disease; or of pretreatment H. pylori isolates [4 -13] a reappearing infection 32 months after successful eradication.
H. pylori chromosomal DNA isolation. After being thawed, DNA profile by RFLP of the H. pylori isolates of these 2 bacterial suspensions were grown on horse blood agar plates at 37ЊC in a microaerophilic environment for 3 days. From these patients proved iatrogenic transmission from the patient who plates, 10 single H. pylori colonies were picked, cultured on horse underwent the immediately previous endoscopy [14] . After blood agar, and harvested again. From the cultures of individual 1988, when endoscopic cleaning procedures were improved, colonies, chromosomal DNA was isolated as described [14, 16] . H. pylori, a reappearing infection was diagnosed, with recur-PCR was carried out in 25 mL of a mixture of 10 mM TRIS-HCl rence of histologic gastritis. Initially, a reinfection was as- cence of H. pylori already present in that patient before treat- In the remaining 5 patients (D -H), the DNA profiles from pretreatment and recurrent H. pylori isolates were identical. Again, this finding strongly favors recrudescence of the pretreatment H. pylori strain, although reinfection by an identical H. pylori type from a common source cannot be excluded. Histologic examination at the time of reappearing infection showed reactivation of gastritis. Histologic examination of culture-negative controls revealed a decrease in gastritis activity and absence of H. pylori. Whole cell ELISA revealed a sustained high level of anti -H. pylori IgG antibodies in the sera of 5 of 6 recrudescence patients during the complete followup period ( figure 3) ; usually a gradual fall of antibody titers should be noticed after apparent successful eradication, as is illustrated for another 10 patients with successful eradication and no reinfection (figure 4). cannot be spontaneously infected.
Discussion
After proven iatrogenic reinfection before 1988 [14] , endoscopic disinfecting procedures in our institution were improved. Ever since, no additional iatrogenic transmission of H. pylori ment antrum strain (lanes a, e). This patient is illustrative of the difficulties in interpreting the cause of reappearance if the has been observed. After exclusion of the 2 iatrogenically infected patients, the recurrent infection rate was 1.2%/patientmicroorganism originates from a heterogeneous H. pylori population present in an individual. To contrast this finding, DNA year. The frequency of reappearing infections varies in the literaprofiles of H. pylori isolates from patients without successful cure of the infection are demonstrated in figure 2. It illustrates ture because of several pitfalls. Assessment of H. pylori infec- Once reappearance of infection is diagnosed, the DNA profiles of pretreatment and recurrent H. pylori strains must be determined to distinguish between reinfection and recrudescence [13 -15, 24] . The results of this technique should be interpreted carefully, since an individual patient can carry a heterogeneous H. pylori population, as did our patient C. Therefore, multiple colonies from specimens taken simultaneously cumstantial evidence of familial clustering of H. pylori [26] but remains difficult to prove [27] , especially since heterogeneity of H. pylori strains also occurs within families [25] . Recently, tion too early after eradication therapy may result in overestiSchutze et al. [13] found that 2 patients with reappearing infecmation of cure rates and a high reappearance rate [4, 9] . The tion and their respective spouses were infected with identical 4-weeks rule used for posttherapy assessment is generally acstrains. The authors concluded that person-to-person transmiscepted, because most of the recrudescent infections occur dursion had occurred. It should be realized that recrudescence ing this period [7] . In the present study, the 4-weeks posttreator reinfection from the same environmental source with an ment H. pylori assessment represents a specificity of 96%. In H. pylori strain identical to the pretreatment strain could not contrast, the specificity in the study of Coghlan et al. [8] was be excluded. much lower, since cure was assessed immediately after cessation of bismuth therapy, and H. pylori infection reappeared in 33% of patients. Despite assessment of cure 4 weeks after cessation of therapy, Xia et al. [10] , from the same group, reported a reappearing infection rate of 18.9% (range, 9.2% -47.1%). Those authors concluded that this was obviously not reappearance of infection but recrudescence after use of less effective therapies, which may only suppress rather than eradicate the microorganism. Moreover, they suggested more sensitive techniques to assess H. pylori infection [10] .
We have demonstrated that recrudescence remains possible 12 and even 33 months after successful eradication with lesseffective bismuth therapies. Our 6 patients with recrudescence were treated with bismuth monotherapy, bismuth dual therapy, or bismuth triple therapy. The relation between high rate of reappearance of infection and less-effective H. pylori eradication regimens is also supported by the near-zero reappearance rates that have been noted since more-effective eradication regimens have been used [19 -21] . 
